Browse 15 Life Science companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Bactolife is a biotechnology company that develops biological solutions to support gut health.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
View all companies funded by Novo Holdings across every industry and funding stage.
View Full Novo Holdings Portfolio